Baring Asia buys Japanese drug maker from Tokio Marine
Baring Private Equity Asia has agreed to buy Japan-based Bushu Pharmaceuticals from Tokio Marine Capital at an enterprise valuation of JPY77.3 billion ($670 million).
According to AVCJ Research, Tokio Marine-managed TMCAP2005 - a JPY32.6 billion fund raised in 2005 - purchased Bushu from Shionogi & Co. for JPY8.56 billion (then $93 million) in 2010. Baring Asia's acquisition...
More on Exits
Latest News
ESG backlash: Turbulent tailwinds
The strong momentum behind sustainable and responsible investment policies globally has begun to ruffle feathers in the US. Asian private equity should recognise this as a relevant warning
Deal focus: KKR makes an impact with GreenCollar
KKR helped GreenCollar take advantage of carbon credit markets that have become increasingly global and economically viable – and it took dozens of employees along for the ride
Profile: Venturra’s John Riady
A millennial member of one of Indonesia’s most prominent family business groups, John Riady became a VC investor in 2011. He has witnessed a nascent digital economy begin to fulfil its promise
Novo Tellus hits $375m first close on third Indo-Pacific fund
Novo Tellus Capital Partners, an investor in industrial technology assets across the Indo-Pacific region, has reached a first close of approximately USD 375m on its third fund – matching the overall target for the vehicle.